Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-312024-04-01falseNo description of principal activity22truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 08937232 2024-04-01 2025-03-31 08937232 2023-04-01 2024-03-31 08937232 2025-03-31 08937232 2024-03-31 08937232 c:Director1 2024-04-01 2025-03-31 08937232 d:OfficeEquipment 2024-04-01 2025-03-31 08937232 d:OfficeEquipment 2025-03-31 08937232 d:OfficeEquipment 2024-03-31 08937232 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 08937232 d:CurrentFinancialInstruments 2025-03-31 08937232 d:CurrentFinancialInstruments 2024-03-31 08937232 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 08937232 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 08937232 d:ShareCapital 2025-03-31 08937232 d:ShareCapital 2024-03-31 08937232 d:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 08937232 d:RetainedEarningsAccumulatedLosses 2025-03-31 08937232 d:RetainedEarningsAccumulatedLosses 2024-03-31 08937232 c:OrdinaryShareClass1 2024-04-01 2025-03-31 08937232 c:OrdinaryShareClass1 2025-03-31 08937232 c:OrdinaryShareClass1 2024-03-31 08937232 c:FRS102 2024-04-01 2025-03-31 08937232 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 08937232 c:FullAccounts 2024-04-01 2025-03-31 08937232 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 08937232 6 2024-04-01 2025-03-31 08937232 e:PoundSterling 2024-04-01 2025-03-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 08937232



DR JOHN GLEES LIMITED


UNAUDITED
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED 31 MARCH 2025

 
DR JOHN GLEES LIMITED
REGISTERED NUMBER: 08937232

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
4,687
8,492

Investments
 5 
26,175
26,175

  
30,862
34,667

Current assets
  

Debtors: amounts falling due within one year
 6 
27,702
39,894

Cash at bank and in hand
 7 
305,052
255,472

  
332,754
295,366

Creditors: amounts falling due within one year
 8 
(29,628)
(26,874)

Net current assets
  
 
 
303,126
 
 
268,492

Total assets less current liabilities
  
333,988
303,159

  

Net assets
  
333,988
303,159


Capital and reserves
  

Called up share capital 
 9 
100
100

Profit and loss account
 10 
333,888
303,059

  
333,988
303,159


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 17 November 2025.


Page 1

 
DR JOHN GLEES LIMITED
REGISTERED NUMBER: 08937232
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2025



John Glees
Director

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
DR JOHN GLEES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
1.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
1.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
1.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.


Page 3

 
DR JOHN GLEES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.Accounting policies (continued)

 
1.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
3 year straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
1.6

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each reporting date. Gains and losses on remeasurement are recognised in the Statement of income and retained earnings for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each reporting date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
1.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
1.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
1.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 4

 
DR JOHN GLEES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.


Judgments in applying accounting policies and key sources of estimation uncertainty

In the application of the company's accounting policies management is required to make judgements, estimates and assumptions about the carrying value of assets and liabilities that are not readily ascertainable from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual outcomes may differ from these estimates.
The estimates and underlying assumptions are reviewed on a continuing basis. Revisions to accounting estimates are recognised in the period in which the estimates are revised.
The key areas of estimation uncertainty that have a significant effect on the amounts recognised in the financial statements are described below:
Accrued Expenditure
The company includes a provision for invoices which are yet to be received from and amounts paid in advance to suppliers. These provisions are estimated based upon the expected values of the invoices which are issued and services received following the period end.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2024 - 2).

Page 5

 
DR JOHN GLEES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

4.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 April 2024
23,883


Additions
1,199



At 31 March 2025

25,082



Depreciation


At 1 April 2024
15,391


Charge for the year on owned assets
5,004



At 31 March 2025

20,395



Net book value



At 31 March 2025
4,687



At 31 March 2024
8,492

Page 6

 
DR JOHN GLEES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

5.


Fixed asset investments





Listed investments

£



Cost or valuation


At 1 April 2024
26,175



At 31 March 2025
26,175





6.


Debtors

2025
2024
£
£


Trade debtors
8,612
20,805

Amounts owed by joint ventures and associated undertakings
19,020
19,020

Other debtors
70
69

27,702
39,894



7.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
305,052
255,472

305,052
255,472



8.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
90
4,953

Corporation tax
9,928
4,521

Other creditors
17,210
15,000

Accruals and deferred income
2,400
2,400

29,628
26,874


Page 7

 
DR JOHN GLEES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

9.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



100 (2024 - 100) Ordinary Shares shares of £1.00 each
100
100



10.


Reserves

Profit and loss account

The profit and loss account is fully distributable.


11.


Related party transactions

At the balance sheet date, the company owed £16,499 to Dr John Glees, a director and shareholder (2024 - £14,290).
At the balance sheet date, the company was owed £19,020 (2024 - £19,020) by Dr Crespo Limited, a company where Dr Jose Manuel Sanchez-Crespo Urbina is the sole director and shareholder.

 
Page 8